Hot or Nothing
See My Plan
Woman in a floral dress sitting on rocks by the sea in warm golden sunlight

How Much Weight Can You Lose on Tirzepatide in 3 Months?

How much weight can you lose on tirzepatide in 3 months?

Reviewed by Taylor Anderson, RN

Aesthetic Registered Nurse

Taylor Anderson is an aesthetic registered nurse and a reviewer for Hot or Nothing.

Updated October 18, 2026

Quick answer

Most people lose about 1 pound out of every 20 they weigh in their first 3 months on tirzepatide. That is about 9 pounds if you start at 180 pounds. Tirzepatide is still on low starter doses during those weeks and steps up every 4 weeks or more toward the doses that do most of the work, so the bigger losses come later. If you lose less than that early on, staying on tirzepatide usually gets you there, often by about 6 months.

In this guide

Key takeaways

  • Most people on tirzepatide lose about 9 pounds by 3 months if they start at 180 pounds, alongside eating about 500 calories a day less and moving about 150 minutes a week.
  • Three months is early to judge tirzepatide, because the dose starts low, steps up every 4 weeks or more, and the highest dose can take about 5 months to reach.
  • A slow start on tirzepatide is common and usually catches up with time, though slow starters tend to end with about half the total loss of fast starters.
  • Women on tirzepatide kept losing well past month 3, and their waists shrank by about 8 inches over roughly a year and a half.
  • Stomach side effects show up mostly while the dose is going up, so tell your clinical team if a step-up hits hard, and use a backup to the birth control pill for 4 weeks after you start and after each dose increase.

Most people lose at least 5% of their body weight in the first 3 months on tirzepatide. In an analysis of the SURMOUNT-1 trial, 82% of the 1,545 people who took at least three-quarters of their doses had lost 5% or more by week 12. If you start at 180 pounds, 5% is 9 pounds.

Three months is the slow part, though. Tirzepatide starts at a low dose and steps up every 4 weeks or more, so you spend these weeks climbing toward the dose that does most of the work. Women in SURMOUNT-1 averaged 23% to 26% weight loss by 72 weeks. Most people who had lost less than 5% at 3 months still got there by staying on it.

How much weight do most people lose on tirzepatide in 3 months?

Most people lose at least 5% of their weight by 3 months. In the SURMOUNT-1 analysis, 1,267 of 1,545 people (82%) who stayed on treatment had reached that by week 12. The other 278 (18%) had lost less.

The people in that trial also had help. Everyone in SURMOUNT-1 got regular counselling to eat about 500 calories a day less and to move at least 150 minutes a week. The results came from the medicine plus those habits, not the medicine alone.

You do not need to feel sick for tirzepatide to work. Across four tirzepatide trials, people lost about the same amount of weight whether they had no nausea, nausea alone, or any nausea, vomiting or diarrhea. Stomach side effects accounted for no more than 3.1% of the total weight lost.

For one poster, the big change was hunger. The poster in r/tirzepatidecompound, who went from 265 to 200 pounds in 7 months at 69 on compounded tirzepatide, described it like this: "The reduction in hunger, and especially the urge to overeat, made doing everything else much easier."

Why is 3 months too early to judge tirzepatide?

At 3 months, you are still climbing through the starter doses. According to the tirzepatide label, you start at 2.5 mg once a week for 4 weeks. That dose is not meant to be a maintenance dose. Then you move to 5 mg, and after that the dose can go up in 2.5 mg steps once you have been on your current dose for at least 4 weeks. Going up slowly lowers the risk of stomach side effects.

The trial followed the same slow climb. In SURMOUNT-1, people aiming for 5 mg reached it at week 4. People aiming for 10 mg reached it at week 12, and people aiming for 15 mg did not get there until week 20. Higher doses went with more people reaching weight loss milestones at weeks 24 and 72. Judging at week 12 means judging before many people had reached their full dose.

You may have heard that you should stop a weight loss drug if you have not lost 5% by 12 weeks. That rule comes from guidelines published in 2015, before medicines this effective were available. The SURMOUNT-1 researchers found that following it would have stopped most slow starters before they reached a meaningful loss.

The step-ups can be bumpy. A poster in r/Zepbound wrote in a thread about hitting her goals: "Had a little setback when I upped my dose to 5mg last month and had some pretty rough GI side effects and dehydration." If a dose increase hits you like that, tell your clinical team. Do not change your dose on your own.

What if I've lost less than 5% by 3 months on tirzepatide?

If you have lost less than 5% by 3 months, you will most likely still get there. Here is how slow starters and fast starters did in SURMOUNT-1:

Slow starters (under 5% at week 12) Fast starters (5% or more at week 12)
Share of people 18% 82%
Lost at least 5% by week 24 70% Already there at week 12
Lost at least 5% by week 72 90% Already there at week 12
Average loss at week 72 11.0% (12.0 kg, about 26 pounds) 22.5% (23.2 kg, about 51 pounds)

A slow start was common and usually temporary. Slow starters who reached 5% took about 25 weeks on average, or roughly 6 months. Only 28 of the 1,545 people in the analysis (1.8%) were still under 5% at week 72.

A slow start does tell you something, though. Slow starters lost about half as much as fast starters by 72 weeks. They lost less at every dose, and across the trial, a bigger loss at week 12 went with a bigger loss at the end. You are not stuck, but your total may come in lower.

Slow starters were more likely to be men (45% compared with 30% of fast starters). They also tended to start heavier, at an average of 110.2 kg compared with 103.6 kg, and with a higher BMI (39.1 compared with 37.7).

How much do women lose on tirzepatide after the first 3 months?

Women kept losing well past month 3, whatever their stage of life. By 72 weeks in SURMOUNT-1, women on tirzepatide had lost an average of 26% of their body weight before menopause, 23% in perimenopause and 23% after menopause. Women on placebo lost 2% to 3%.

Their waists shrank too. Waist measurements dropped by 20 to 22 cm (roughly 8 inches) on tirzepatide, compared with 4 to 5 cm on placebo.

Almost every woman reached a meaningful loss eventually. Between 97% and 98% of women on tirzepatide lost at least 5% of their weight, compared with 29% to 33% on placebo.

What side effects should I expect in the first 3 months of tirzepatide?

Stomach side effects are the main ones, and they mostly happen while your dose is going up. Across the SURMOUNT-1 to -4 trials, 27.8% to 72.8% of people on tirzepatide had at least one stomach side effect, compared with 12.2% to 32.5% on placebo. Most were mild to moderate and faded over time. Between 1.0% and 10.5% of people stopped tirzepatide because of them.

Drink enough when you have nausea, vomiting or diarrhea. Some people taking tirzepatide and similar drugs have developed kidney injury, sometimes serious enough to need dialysis, and most of them had become dehydrated from stomach side effects. If you cannot keep fluids down, tell your clinical team, especially when you start or step up a dose.

If you take the birth control pill, tirzepatide can make it less reliable. The label advises switching to a method that is not a pill, or adding a barrier method such as condoms, for 4 weeks after you start and for 4 weeks after each dose increase. In your first 3 months, that covers most of the time.

Tirzepatide is not for you if you or anyone in your family has had medullary thyroid cancer, or if you have MEN 2, an inherited condition that causes tumors in hormone glands. In rats, tirzepatide caused thyroid tumors. It is not known whether it does this in people. Tell your clinical team about your family history.

The first 3 months on tirzepatide are about reaching the dose that does the work while keeping side effects manageable. That is easier when a clinical team is adjusting your plan with you. Our clinical team can prescribe tirzepatide if it fits your goal. Take the quiz to see whether it fits yours.

Ready to make a move?

Answer three questions to see the treatment options that fit your goals.

See My Plan

FAQ

When does tirzepatide start working for weight loss?

Tirzepatide starts working within the first 3 months for most people, who lose at least 5% of their body weight by week 12 while still on starter doses. The bigger losses come later, once you reach the dose that does most of the work, which can take up to 20 weeks. If your start is slower, people who lost less early on took about 6 months on average to reach that 5% mark.

Can you lose 20 pounds in 3 months on tirzepatide?

That depends on where you start. Most people lose at least 5% of their weight by 3 months, which is 9 pounds from 180 pounds or 12.5 pounds from 250 pounds, so 20 pounds is more than that early mark for most starting weights. People who lost more in the first 12 weeks tended to lose more by the end.

How much weight do people lose on tirzepatide in a year?

The trial results in this article run to 72 weeks, about 17 months, rather than one year. By then women on tirzepatide had lost an average of 23% to 26% of their body weight, depending on whether they were before, during or after menopause. Fast starters averaged a 22.5% loss and slow starters averaged 11.0%.

Do you have to diet while taking tirzepatide?

Tirzepatide is meant to go with eating less and moving more. Everyone in the trial got regular counselling to eat about 500 calories a day less and move at least 150 minutes a week, so the results came from the medicine plus those habits. One poster said the drop in hunger, and especially the urge to overeat, made everything else much easier.

Keep reading

Sources (5)
  1. Weight reduction over time in tirzepatide‐treated participants by early weight loss response: Post hoc analysis in SURMOUNT‐1 - PMC · pmc.ncbi.nlm.nih.gov · captured October 18, 2026
  2. Gastrointestinal tolerability and weight reduction associated with tirzepatide in adults with obesity or overweight with and without type 2 diabetes in the SURMOUNT‐1 to ‐4 trials - PMC · pmc.ncbi.nlm.nih.gov · captured October 18, 2026
  3. r/tirzepatidecompound: Apparently 69 isn’t too late: 265 to 200 in 7 months on compounded tirzepatide · reddit.com · captured October 18, 2026
  4. r/Zepbound: Hitting my goals · reddit.com · captured October 18, 2026
  5. Approval Label · accessdata.fda.gov · captured October 18, 2026